{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:33:28Z","timestamp":1787895208946,"version":"build-2784847793"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T00:00:00Z","timestamp":1362873600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T00:00:00Z","timestamp":1362873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/nm.3118","type":"journal-article","created":{"date-parts":[[2013,3,10]],"date-time":"2013-03-10T19:20:30Z","timestamp":1362943230000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis"],"prefix":"10.1038","volume":"19","author":[{"given":"Gangwen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Cotrim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Silvio","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Raben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"ten Dijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosef","family":"Refaeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,10]]},"reference":[{"key":"BFnm3118_CR1","first-page":"199","volume":"4","author":"ST Sonis","year":"2010","unstructured":"Sonis, S.T. Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evid. 4, 199\u2013205 (2010).","journal-title":"Core Evid."},{"key":"BFnm3118_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/bmt.2010.184","volume":"46","author":"L Vagliano","year":"2011","unstructured":"Vagliano, L. et al. Incidence and severity of oral mucositis in patients undergoing haematopoietic SCT\u2014results of a multicentre study. Bone Marrow Transplant. 46, 727\u2013732 (2011).","journal-title":"Bone Marrow Transplant."},{"key":"BFnm3118_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","volume":"12","author":"C Scully","year":"2006","unstructured":"Scully, C., Sonis, S. & Diz, P.D. Oral mucositis. Oral Dis. 12, 229\u2013241 (2006).","journal-title":"Oral Dis."},{"key":"BFnm3118_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2217\/fon.10.133","volume":"6","author":"JC Wu","year":"2010","unstructured":"Wu, J.C., Beale, K.K. & Ma, J.D. Evaluation of current and upcoming therapies in oral mucositis prevention. Future Oncol. 6, 1751\u20131770 (2010).","journal-title":"Future Oncol."},{"key":"BFnm3118_CR5","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1200\/JCO.2010.32.4103","volume":"29","author":"M Henke","year":"2011","unstructured":"Henke, M. et al. Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J. Clin. Oncol. 29, 2815\u20132820 (2011).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3118_CR6","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1200\/JCO.2010.32.4095","volume":"29","author":"QT Le","year":"2011","unstructured":"Le, Q.T. et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J. Clin. Oncol. 29, 2808\u20132814 (2011).","journal-title":"J. Clin. Oncol."},{"key":"BFnm3118_CR7","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1073\/pnas.0805159106","volume":"106","author":"J Zhao","year":"2009","unstructured":"Zhao, J. et al. R-Spondin1 protects mice from chemotherapy or radiation-induced oral mucositis through the canonical Wnt\/\u03b2-catenin pathway. Proc. Natl. Acad. Sci. USA 106, 2331\u20132336 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3118_CR8","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1002\/cncr.24414","volume":"115","author":"HG Wu","year":"2009","unstructured":"Wu, H.G. et al. Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial. Cancer 115, 3699\u20133708 (2009).","journal-title":"Cancer"},{"key":"BFnm3118_CR9","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/17425255.2011.566556","volume":"7","author":"C Weigelt","year":"2011","unstructured":"Weigelt, C., Haas, R. & Kobbe, G. Pharmacokinetic evaluation of palifermin for mucosal protection from chemotherapy and radiation. Expert Opin. Drug Metab. Toxicol. 7, 505\u2013515 (2011).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"BFnm3118_CR10","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1002\/cncr.24525","volume":"115","author":"R Haddad","year":"2009","unstructured":"Haddad, R. et al. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin\/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer 115, 4514\u20134523 (2009).","journal-title":"Cancer"},{"key":"BFnm3118_CR11","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.ijrobp.2011.09.026","volume":"83","author":"AP Cotrim","year":"2012","unstructured":"Cotrim, A.P. et al. Pharmacological protection from radiation +\/\u2212 cisplatin-induced oral mucositis. Int. J. Radiat. Oncol. Biol. Phys. 83, 1284\u20131290 (2012).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"BFnm3118_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.stem.2012.06.007","volume":"11","author":"R Iglesias-Bartolome","year":"2012","unstructured":"Iglesias-Bartolome, R. et al. mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11, 401\u2013414 (2012).","journal-title":"Cell Stem Cell"},{"key":"BFnm3118_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000321051","volume":"40","author":"SK Fistarol","year":"2011","unstructured":"Fistarol, S.K. & Itin, P.H. Anti-inflammatory treatment. Curr. Probl. Dermatol. 40, 58\u201370 (2011).","journal-title":"Curr. Probl. Dermatol."},{"key":"BFnm3118_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1517\/14728214.2010.528389","volume":"15","author":"S Elad","year":"2010","unstructured":"Elad, S. et al. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part I: calcineurin inhibitors. Expert Opin. Emerg. Drugs 15, 713\u2013726 (2010).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"BFnm3118_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1517\/14728214.2011.528390","volume":"16","author":"S Elad","year":"2011","unstructured":"Elad, S. et al. Topical immunomodulators for management of oral mucosal conditions, a systematic review; part II: miscellaneous agents. Expert Opin. Emerg. Drugs 16, 183\u2013202 (2011).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"BFnm3118_CR16","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0714.2008.00693.x","volume":"37","author":"ID O'Neill","year":"2008","unstructured":"O'Neill, I.D. Off-label use of biologicals in the management of inflammatory oral mucosal disease. J. Oral Pathol. Med. 37, 575\u2013581 (2008).","journal-title":"J. Oral Pathol. Med."},{"key":"BFnm3118_CR17","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/emboj\/21.11.2580","volume":"21","author":"W He","year":"2002","unstructured":"He, W. et al. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J. 21, 2580\u20132590 (2002).","journal-title":"EMBO J."},{"key":"BFnm3118_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/ni1451","volume":"8","author":"S Hong","year":"2007","unstructured":"Hong, S. et al. Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat. Immunol. 8, 504\u2013513 (2007).","journal-title":"Nat. Immunol."},{"key":"BFnm3118_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.devcel.2006.06.014","volume":"11","author":"G Han","year":"2006","unstructured":"Han, G. et al. Smad7-induced \u03b2-catenin degradation alters epidermal appendage development. Dev. Cell 11, 301\u2013312 (2006).","journal-title":"Dev. Cell"},{"key":"BFnm3118_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0167-8140(03)00231-7","volume":"69","author":"JF Fowler","year":"2003","unstructured":"Fowler, J.F., Harari, P.M., Leborgne, F. & Leborgne, J.H. Acute radiation reactions in oral and pharyngeal mucosa: tolerable levels in altered fractionation schedules. Radiother. Oncol. 69, 161\u2013168 (2003).","journal-title":"Radiother. Oncol."},{"key":"BFnm3118_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/359693a0","volume":"359","author":"MM Shull","year":"1992","unstructured":"Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-\u03b2 1 gene results in multifocal inflammatory disease. Nature 359, 693\u2013699 (1992).","journal-title":"Nature"},{"key":"BFnm3118_CR22","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1073\/pnas.90.2.770","volume":"90","author":"AB Kulkarni","year":"1993","unstructured":"Kulkarni, A.B. et al. Transforming growth factor \u03b2 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770\u2013774 (1993).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3118_CR23","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1158\/0008-5472.CAN-04-1032","volume":"64","author":"SL Lu","year":"2004","unstructured":"Lu, S.L. et al. Overexpression of transforming growth factor \u03b21 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 64, 4405\u20134410 (2004).","journal-title":"Cancer Res."},{"key":"BFnm3118_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20101827","volume":"434","author":"X Yan","year":"2011","unstructured":"Yan, X. & Chen, Y.G. Smad7: not only a regulator, but also a cross-talk mediator of TGF-\u03b2 signalling. Biochem. J. 434, 1\u201310 (2011).","journal-title":"Biochem. J."},{"key":"BFnm3118_CR25","doi-asserted-by":"publisher","first-page":"e10503","DOI":"10.1371\/journal.pone.0010503","volume":"5","author":"RM Castilho","year":"2010","unstructured":"Castilho, R.M. et al. Rac1 is required for epithelial stem cell function during dermal and oral mucosal wound healing but not for tissue homeostasis in mice. PLoS ONE 5, e10503 (2010).","journal-title":"PLoS ONE"},{"key":"BFnm3118_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1524-475x.2000.00179.x","volume":"8","author":"RM Koch","year":"2000","unstructured":"Koch, R.M. et al. Incisional wound healing in transforming growth factor-\u03b21 null mice. Wound Repair Regen. 8, 179\u2013191 (2000).","journal-title":"Wound Repair Regen."},{"key":"BFnm3118_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S1359-6101(99)00036-2","volume":"11","author":"GS Ashcroft","year":"2000","unstructured":"Ashcroft, G.S. & Roberts, A.B. Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev. 11, 125\u2013131 (2000).","journal-title":"Cytokine Growth Factor Rev."},{"key":"BFnm3118_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang, Y.E. Non-Smad pathways in TGF-\u03b2 signaling. Cell Res. 19, 128\u2013139 (2009).","journal-title":"Cell Res."},{"key":"BFnm3118_CR29","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1016\/j.febslet.2006.04.033","volume":"580","author":"J Massagu\u00e9","year":"2006","unstructured":"Massagu\u00e9, J. & Gomis, R.R. The logic of TGF\u03b2 signaling. FEBS Lett. 580, 2811\u20132820 (2006).","journal-title":"FEBS Lett."},{"key":"BFnm3118_CR30","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1101\/gad.1350705","volume":"19","author":"J Massagu\u00e9","year":"2005","unstructured":"Massagu\u00e9, J., Seoane, J. & Wotton, D. Smad transcription factors. Genes Dev. 19, 2783\u20132810 (2005).","journal-title":"Genes Dev."},{"key":"BFnm3118_CR31","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1172\/JCI43304","volume":"120","author":"KE Hoot","year":"2010","unstructured":"Hoot, K.E. et al. HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J. Clin. Invest. 120, 3606\u20133616 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnm3118_CR32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.addr.2004.12.001","volume":"57","author":"H Brooks","year":"2005","unstructured":"Brooks, H., Lebleu, B. & Vives, E. Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57, 559\u2013577 (2005).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnm3118_CR33","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/j.1600-0854.2007.00696.x","volume":"9","author":"F Cardarelli","year":"2008","unstructured":"Cardarelli, F., Serresi, M., Bizzarri, R. & Beltram, F. Tuning the transport properties of HIV-1 Tat arginine-rich motif in living cells. Traffic 9, 528\u2013539 (2008).","journal-title":"Traffic"},{"key":"BFnm3118_CR34","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1093\/nar\/gkq486","volume":"38","author":"A Kalvala","year":"2010","unstructured":"Kalvala, A. et al. Enhancement of gene targeting in human cells by intranuclear permeation of the Saccharomyces cerevisiae Rad52 protein. Nucleic Acids Res. 38, e149 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFnm3118_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2004.12.006","volume":"75","author":"W D\u00f6rr","year":"2005","unstructured":"D\u00f6rr, W., Reichel, S. & Spekl, K. Effects of keratinocyte growth factor (palifermin) administration protocols on oral mucositis (mouse) induced by fractionated irradiation. Radiother. Oncol. 75, 99\u2013105 (2005).","journal-title":"Radiother. Oncol."},{"key":"BFnm3118_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/09553000500196136","volume":"81","author":"W D\u00f6rr","year":"2005","unstructured":"D\u00f6rr, W., Heider, K. & Spekl, K. Reduction of oral mucositis by palifermin (rHuKGF): dose-effect of rHuKGF. Int. J. Radiat. Biol. 81, 557\u2013565 (2005).","journal-title":"Int. J. Radiat. Biol."},{"key":"BFnm3118_CR37","first-page":"4506","volume":"61","author":"B Singh","year":"2001","unstructured":"Singh, B. et al. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res. 61, 4506\u20134513 (2001).","journal-title":"Cancer Res."},{"key":"BFnm3118_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.canlet.2006.01.003","volume":"245","author":"W Qiu","year":"2007","unstructured":"Qiu, W., Schonleben, F., Li, X. & Su, G.H. Disruption of transforming growth factor \u03b2\u2013Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett. 245, 163\u2013170 (2007).","journal-title":"Cancer Lett."},{"key":"BFnm3118_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","volume":"134","author":"J Massagu\u00e9","year":"2008","unstructured":"Massagu\u00e9, J. TGF\u03b2 in Cancer. Cell 134, 215\u2013230 (2008).","journal-title":"Cell"},{"key":"BFnm3118_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcp.10066","volume":"191","author":"P Ten Dijke","year":"2002","unstructured":"Ten Dijke, P., Goumans, M.J., Itoh, F. & Itoh, S. Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191, 1\u201316 (2002).","journal-title":"J. Cell Physiol."},{"key":"BFnm3118_CR41","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck, R. & Zhang, Y.E. Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling. Nature 425, 577\u2013584 (2003).","journal-title":"Nature"},{"key":"BFnm3118_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nature00820","volume":"417","author":"M Pasparakis","year":"2002","unstructured":"Pasparakis, M. et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417, 861\u2013866 (2002).","journal-title":"Nature"},{"key":"BFnm3118_CR43","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1517\/14712598.2011.580271","volume":"11","author":"P Maier","year":"2011","unstructured":"Maier, P., Veldwijk, M.R. & Wenz, F. Radioprotective gene therapy. Expert Opin. Biol. Ther. 11, 1135\u20131151 (2011).","journal-title":"Expert Opin. Biol. Ther."},{"key":"BFnm3118_CR44","first-page":"3408","volume":"119","author":"S Bornstein","year":"2009","unstructured":"Bornstein, S. et al. Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J. Clin. Invest. 119, 3408\u20133419 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnm3118_CR45","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1101\/gad.1413306","volume":"20","author":"SL Lu","year":"2006","unstructured":"Lu, S.L. et al. Loss of transforming growth factor-\u03b2 type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev. 20, 1331\u20131342 (2006).","journal-title":"Genes Dev."},{"key":"BFnm3118_CR46","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd3810","volume":"11","author":"RJ Akhurst","year":"2012","unstructured":"Akhurst, R.J. & Hata, A. Targeting the TGF\u03b2 signalling pathway in disease. Nat. Rev. Drug Discov. 11, 790\u2013811 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFnm3118_CR47","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1476-5381.2009.00057.x","volume":"157","author":"F Heitz","year":"2009","unstructured":"Heitz, F., Morris, M.C. & Divita, G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 157, 195\u2013206 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFnm3118_CR48","doi-asserted-by":"publisher","first-page":"4641","DOI":"10.1158\/1078-0432.CCR-09-0819","volume":"15","author":"C Zheng","year":"2009","unstructured":"Zheng, C. et al. Prevention of radiation-induced oral mucositis after adenoviral vector\u2013mediated transfer of the keratinocyte growth factor cDNA to mouse submandibular glands. Clin. Cancer Res. 15, 4641\u20134648 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnm3118_CR49","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1016\/j.ajpath.2011.06.003","volume":"179","author":"G Han","year":"2011","unstructured":"Han, G., Li, F., Ten Dijke, P. & Wang, X.J. Temporal smad7 transgene induction in mouse epidermis accelerates skin wound healing. Am. J. Pathol. 179, 1768\u20131779 (2011).","journal-title":"Am. J. Pathol."},{"key":"BFnm3118_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(03)00802-X","volume":"115","author":"Q Zhang","year":"2003","unstructured":"Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S.M. & Goodman, R.H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115, 177\u2013186 (2003).","journal-title":"Cell"},{"key":"BFnm3118_CR51","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1128\/MCB.00439-09","volume":"29","author":"LM Bergman","year":"2009","unstructured":"Bergman, L.M., Birts, C.N., Darley, M., Gabrielli, B. & Blaydes, J.P. CtBPs promote cell survival through the maintenance of mitotic fidelity. Mol. Cell Biol. 29, 4539\u20134551 (2009).","journal-title":"Mol. Cell Biol."},{"key":"BFnm3118_CR52","doi-asserted-by":"publisher","first-page":"9577","DOI":"10.1158\/0008-5472.CAN-07-1179","volume":"67","author":"S Hong","year":"2007","unstructured":"Hong, S., Lee, C. & Kim, S.J. Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-\u03baB pathway. Cancer Res. 67, 9577\u20139583 (2007).","journal-title":"Cancer Res."},{"key":"BFnm3118_CR53","first-page":"21","volume":"110","author":"A Munshi","year":"2005","unstructured":"Munshi, A., Hobbs, M. & Meyn, R.E. Clonogenic cell survival assay. Methods Mol. Med. 110, 21\u201328 (2005).","journal-title":"Methods Mol. Med."},{"key":"BFnm3118_CR54","doi-asserted-by":"publisher","first-page":"7836","DOI":"10.1158\/0008-5472.CAN-04-1331","volume":"64","author":"AG Li","year":"2004","unstructured":"Li, A.G., Lu, S.L., Zhang, M.X., Deng, C. & Wang, X.J. Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res. 64, 7836\u20137845 (2004).","journal-title":"Cancer Res."},{"key":"BFnm3118_CR55","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1093\/emboj\/21.11.2580","volume":"21","author":"W He","year":"2002","unstructured":"He, W. et al. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J. 21, 2580\u20132590 (2002).","journal-title":"EMBO J."},{"key":"BFnm3118_CR56","first-page":"2722","volume":"118","author":"KE Hoot","year":"2008","unstructured":"Hoot, K.E. et al. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J. Clin. Invest. 118, 2722\u20132732 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnm3118_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ydbio.2008.07.020","volume":"322","author":"P Owens","year":"2008","unstructured":"Owens, P. et al. Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. Dev. Biol. 322, 155\u2013166 (2008).","journal-title":"Dev. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nm.3118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nm.3118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T18:07:56Z","timestamp":1650046076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,10]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFnm3118"],"URL":"https:\/\/doi.org\/10.1038\/nm.3118","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,10]]},"assertion":[{"value":"6 November 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}